Boston Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $2.98M | Buy |
57,003
+26,122
| +85% | +$1.37M | 0.16% | 179 |
|
|
2019
Q2 | $1.49M | Sell |
30,881
-147
| -0.5% | -$7.1K | 0.08% | 268 |
|
|
2019
Q1 | $1.57M | Sell |
31,028
-8,839
| -22% | -$447K | 0.08% | 260 |
|
|
2018
Q4 | $2.36M | Sell |
39,867
-76,145
| -66% | -$4.51M | 0.14% | 185 |
|
|
2018
Q3 | $7.64M | Sell |
116,012
-2,810
| -2% | -$185K | 0.33% | 74 |
|
|
2018
Q2 | $6M | Sell |
118,822
-34,150
| -22% | -$1.72M | 0.15% | 147 |
|
|
2018
Q1 | $8.05M | Buy |
152,972
+20,640
| +16% | +$1.09M | 0.21% | 105 |
|
|
2017
Q4 | $6.15M | Buy |
132,332
+117,867
| +815% | +$5.48M | 0.13% | 180 |
|
|
2017
Q3 | $585K | Buy |
+14,465
| New | +$585K | 0.01% | 455 |
|
|
2017
Q1 | – | Sell |
-20,685
| Closed | -$679K | – | 632 |
|
|
2016
Q4 | $679K | Buy |
20,685
+8,730
| +73% | +$287K | 0.02% | 415 |
|
|
2016
Q3 | $377K | Buy |
11,955
+3,495
| +41% | +$110K | 0.01% | 567 |
|
|
2016
Q2 | $238K | Sell |
8,460
-12,680
| -60% | -$357K | 0.01% | 642 |
|
|
2016
Q1 | $768K | Buy |
21,140
+4,920
| +30% | +$179K | 0.02% | 363 |
|
|
2015
Q4 | $649K | Hold |
16,220
| – | – | 0.02% | 405 |
|
|
2015
Q3 | $462K | Buy |
16,220
+9,220
| +132% | +$263K | 0.02% | 545 |
|
|
2015
Q2 | $231K | Buy |
+7,000
| New | +$231K | 0.01% | 630 |
|